Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean aromatase inhibitor?
Displaying drugs 1851 - 1875 of 2444 in total
U-0126 is a direct inhibitor of the mitogen-activated protein-kinase kinase family members, MEK-1 and MEK-2.
Investigational
Matched Categories: … Enzyme Inhibitors
Investigational
Matched Categories: … Enzyme Inhibitors
Phenethyl Isothiocyanate has been used in trials studying the prevention and treatment of Leukemia, Lung Cancer, Tobacco Use Disorder, and Lymphoproliferative Disorders.
Investigational
Matched Categories: … Enzyme Inhibitors ... Aldehyde Dehydrogenase, antagonists & inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Tyrosine Kinase Inhibitors
Natural interferon alpha or Multiferon is obtained from the leukocyte fraction of human blood following induction with Sendai virus. Interferon alfa contains several naturally occurring IFN-α subtypes and is purified by affinity chromatography. Interferon alpha proteins are mainly involved in innate immune response against viral infection. They come in 13...
Investigational
Matched Categories: … Cytochrome P-450 CYP1A2 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) …
A synthetic purine nucleoside analogue with potential antineoplastic activity.
Investigational
Matched Categories: … Enzyme Inhibitors ... Ribonucleoside Diphosphate Reductase, antagonists & inhibitors
Investigational
Matched Categories: … Enzyme Inhibitors ... Protease Inhibitors ... Serine Protease Inhibitors ... Aldehyde Reductase, antagonists & inhibitors
Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation...
Investigational
Matched Categories: … Cytochrome P-450 CYP3A Inhibitors ... Cytochrome P-450 CYP3A4 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP3A4 Inhibitors (weak) ... Selective Serotonin Reuptake Inhibitors
Experimental
Matched Categories: … Growth Inhibitors ... Angiogenesis Inhibitors
Levonadifloxacin is under investigation in clinical trial NCT03405064 (Comparative Study of Levonadifloxacin (IV and Oral) With Linezolid (IV and Oral) in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)).
Investigational
Matched Categories: … Enzyme Inhibitors ... beta-Lactamase Inhibitors
Experimental
Matched Categories: … Lactoylglutathione Lyase, antagonists & inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Calcium-Transporting ATPases, antagonists & inhibitors
Investigational
Matched Categories: … Enzyme Inhibitors ... Phospholipase A2 Inhibitors
Experimental
Matched Categories: … P-glycoprotein inhibitors ... ATP Binding Cassette Transporter, Subfamily B, Member 1, antagonists & inhibitors
Sparteine is a plant alkaloid derived from Cytisus scoparius and Lupinus mutabilis which may chelate calcium and magnesium. It is a sodium channel blocker, so it falls in the category of class 1a antiarrhythmic agents. Sparteine is not currently FDA-approved for human use, and its salt, sparteine sulfate, is one...
Experimental
Withdrawn
Matched Categories: … Cytochrome P-450 CYP2D6 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) …
Experimental
Matched Categories: … Cytochrome P-450 CYP1A2 Inhibitors ... Cytochrome P-450 Enzyme Inhibitors ... Cytochrome P-450 CYP1A2 Inhibitors (weak) …
Experimental
Matched Categories: … Tyrosine Kinase Inhibitors
Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.
Investigational
Matched Categories: … Protein Kinase Inhibitors
Investigational
Matched Categories: … Receptors, Leukotriene B4, antagonists & inhibitors
Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng). Ginsenosides have been the target of research, as they are viewed as the active compounds behind the claims of ginseng's efficacy. Because ginsenosides appear to affect multiple pathways, their effects are complex...
Nutraceutical
Matched Categories: … OATP1B3 inhibitors
AKI-001 is an aurora kinase inhibitor.
Experimental
Matched Categories: … Protein Kinase Inhibitors
Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).
Investigational
Matched Categories: … Furin, antagonists & inhibitors
Petesicatib is under investigation in clinical trial NCT02295332 (A Study of RG7625 in Healthy Volunteers).
Investigational
Matched Categories: … Enzyme Inhibitors
Experimental
Matched Categories: … Enzyme Inhibitors ... Procollagen-Proline Dioxygenase, antagonists & inhibitors
Xanthohumol is under investigation in clinical trial NCT01367431 (Xanthohumol and Metabolic Syndrome).
Investigational
Matched Categories: … Growth Inhibitors ... Angiogenesis Inhibitors
Displaying drugs 1851 - 1875 of 2444 in total